CLINICAL_TRIALS
trial_result
· 2021-05-25
Clinical Trial Update: A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 2 Diabetes Mellitus [Phase 3]
Summary
Phase 3 trial comparing LY2963016 to Lantus in adult Chinese participants with type 2 diabetes completed; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2021-05-25